본문 바로가기

Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2
피인용
Web of Science 61
JCR IF
JCR 2008 2.648
ISSN
0006-291X

저자

  1. 배윤희제1저자부산대학교, 치의학전문대학원, 치의학과, KO
  2. 배문경부산대학교, 치의학전문대학원, 치의학과, 구강생리학교실, KO
  3. 김수륜부산대학교, 치의학전문대학원, 치의학과, KO
  4. Lee, Jung Hoon부산광역시의료원, Dept Ophthalmol, KO
  5. Wee, Hee-Jun충북대학교, Dept Biochem, Sch Med, KO
  6. 배수경교신저자부산대학교, 치의학전문대학원, 치의학과, 치의학과, KO

초록

Adipokines have been known to act as angiogenic regulators in the process of angiogenesis. Recently, we have demonstrated that visfatin, a novel adipokine, has angiogenic activity. However, little has been reported on the underlying mechanism of visfatin-induced angiogenesis. in this study, we report that visfatin-induced angiogenesis is mediated by endothelial fibroblast growth factor-2 (FGF-2). Visfatin increased the levels of FGF-2 mRNA and protein in human endothelial cells. The enhancement in FGF-2 expression was prevented by an inhibitor of the extracellular signal-regulated kinase 1/2 (Erk1/2) pathway. Furthermore, visfatin-induced angiogenesis was reduced by inhibition of FGF-2 receptor kinase or by neutralization of FGF-2 function. Taken together, our results indicate that visfatin-induced endothelial angiogenesis is composed largely of two sequential steps: the induction of Erk1/2-dependent FGF-2 gene expression by visfatin and the Subsequent FGF-2-induced angiogenesis. These data further suggest an integral role for visfatin-FGF-2 signaling axis in modulating endothelial angiogenesis. (C) 2008 Elsevier Inc. All rights reserved

식별자

WoS UID
000262924300009